Who
Mary Kay Ladone
Director
Company insider
Files Form 4 as: Director, Kestra Medical Technologies; Director, Inogen; Director, Bioventus; Director, Novanta; SVP, Corp. Dev., Strat. & IR, Hill-Rom Holdings.
In numbers
- Trades disclosed
- 125
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $3.7M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 6 Mar 2019
- Last trade
- 9 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —7,217 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —7,217 | filing |
| 8 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Sold | $98K3,908 at $25.20 | filing |
| 8 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Sold | $98K3,908 at $25.20 | filing |
| 5 Jun 2026filed 9 Jun 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | —28,081 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | —28,081 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT NovantaElectronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | —1,799 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | —1,799 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT NovantaElectronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 4 Sep 2025filed 8 Sep 2025 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —10,909 | filing |
| 11 Jul 2025filed 14 Jul 2025 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —572 | filing |
News
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 15,000 Shares of Company StockKMTS · dailypolitical.com · 22 Oct 2026Evercore Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)KMTS · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Mary Kay Ladone; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.